(CCI) Crown Castle - Ratings and Ratios
Towers, Fiber, Small Cells, Leasing
CCI EPS (Earnings per Share)
CCI Revenue
Description: CCI Crown Castle September 29, 2025
Crown Castle (NYSE:CCI) owns and operates roughly 40,000 cell towers and about 90,000 route-miles of fiber that support small-cell deployments and dark-fiber solutions in virtually every major U.S. market. The infrastructure portfolio is leased to wireless carriers, broadcasters, and enterprise customers, providing a backbone for the nation’s data, technology, and wireless services.
According to the most recent 10-K (FY 2024), Crown Castle reported a Funds-From-Operations (FFO) of $2.55 billion, representing a 7 % year-over-year increase driven primarily by higher lease rates and new small-cell contracts. The REIT’s dividend yield hovered around 5.2 % and its debt-to-EBITDA ratio stood at 5.8×, reflecting a capital-intensive balance sheet that remains within industry-typical leverage limits but warrants monitoring for interest-rate sensitivity.
The primary economic tailwinds for Crown Castle are the accelerated rollout of 5G networks, which is expected to boost tower-site demand by an estimated 4-5 % annually through 2027, and the growing need for dense small-cell and fiber coverage to support edge-computing and IoT applications. Conversely, a slowdown in carrier capex or a prolonged recession could compress lease-rate growth, introducing downside risk.
For a deeper, data-driven assessment of Crown Castle’s valuation relative to peers, you might find it worthwhile to explore the analytical tools available on ValueRay.
CCI Stock Overview
| Market Cap in USD | 42,889m |
| Sub-Industry | Telecom Tower REITs |
| IPO / Inception | 1998-08-14 |
CCI Stock Ratings
| Growth Rating | -23.8% |
| Fundamental | 34.8% |
| Dividend Rating | 60.0% |
| Return 12m vs S&P 500 | -26.6% |
| Analyst Rating | 3.71 of 5 |
CCI Dividends
| Dividend Yield 12m | 5.82% |
| Yield on Cost 5y | 4.03% |
| Annual Growth 5y | 6.15% |
| Payout Consistency | 99.6% |
| Payout Ratio | 222.0% |
CCI Growth Ratios
| Growth Correlation 3m | -49.2% |
| Growth Correlation 12m | 25.9% |
| Growth Correlation 5y | -77.4% |
| CAGR 5y | -6.47% |
| CAGR/Max DD 3y (Calmar Ratio) | -0.16 |
| CAGR/Mean DD 3y (Pain Ratio) | -0.28 |
| Sharpe Ratio 12m | 0.56 |
| Alpha | -30.87 |
| Beta | 0.963 |
| Volatility | 24.46% |
| Current Volume | 2254.5k |
| Average Volume 20d | 2626.4k |
| Stop Loss | 87.6 (-3%) |
| Signal | -0.11 |
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (-4.62b TTM) > 0 and > 6% of Revenue (6% = 290.5m TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA 4.17pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -65.74% (prev -17.54%; Δ -48.20pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 3.06b > Net Income -4.62b (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 0.26 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (437.0m) change vs 12m ago 0.23% (target <= -2.0% for YES) |
| Gross Margin 73.36% (prev 73.70%; Δ -0.34pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 13.92% (prev 14.58%; Δ -0.66pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -3.17 (EBITDA TTM -2.03b / Interest Expense TTM 942.0m) >= 6 (WARN >= 3) |
Altman Z'' -3.94
| (A) -0.10 = (Total Current Assets 1.11b - Total Current Liabilities 4.30b) / Total Assets 31.50b |
| (B) -0.63 = Retained Earnings (Balance) -19.99b / Total Assets 31.50b |
| (C) -0.09 = EBIT TTM -2.98b / Avg Total Assets 34.77b |
| (D) -0.61 = Book Value of Equity -19.99b / Total Liabilities 32.99b |
| Total Rating: -3.94 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 34.80
| 1. Piotroski 3.0pt = -2.0 |
| 2. FCF Yield 3.68% = 1.84 |
| 3. FCF Margin 55.04% = 7.50 |
| 4. Debt/Equity -19.99 = -2.50 |
| 5. Debt/Ebitda -14.62 = -2.50 |
| 6. ROIC - WACC (= -18.57)% = -12.50 |
| 7. RoE 433.5% = 2.50 |
| 8. Rev. Trend -74.05% = -5.55 |
| 9. EPS Trend -39.61% = -1.98 |
What is the price of CCI shares?
Over the past week, the price has changed by -4.50%, over one month by -3.90%, over three months by -14.79% and over the past year by -11.98%.
Is Crown Castle a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CCI is around 84.19 USD . This means that CCI is currently overvalued and has a potential downside of -6.79%.
Is CCI a buy, sell or hold?
- Strong Buy: 6
- Buy: 3
- Hold: 12
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CCI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 116.1 | 28.5% |
| Analysts Target Price | 116.1 | 28.5% |
| ValueRay Target Price | 91.7 | 1.6% |
CCI Fundamental Data Overview October 29, 2025
P/E Forward = 26.3158
P/S = 6.6806
P/B = 8.8551
P/EG = 1.3257
Beta = 0.963
Revenue TTM = 4.84b USD
EBIT TTM = -2.98b USD
EBITDA TTM = -2.03b USD
Long Term Debt = 23.47b USD (from longTermDebt, last fiscal year)
Short Term Debt = 3.31b USD (from shortTermDebt, last quarter)
Debt = 29.84b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 29.61b USD (from netDebt column, last quarter)
Enterprise Value = 72.50b USD (42.89b + Debt 29.84b - CCE 233.0m)
Interest Coverage Ratio = -3.17 (Ebit TTM -2.98b / Interest Expense TTM 942.0m)
FCF Yield = 3.68% (FCF TTM 2.67b / Enterprise Value 72.50b)
FCF Margin = 55.04% (FCF TTM 2.67b / Revenue TTM 4.84b)
Net Margin = -95.37% (Net Income TTM -4.62b / Revenue TTM 4.84b)
Gross Margin = 73.36% ((Revenue TTM 4.84b - Cost of Revenue TTM 1.29b) / Revenue TTM)
Gross Margin QoQ = 73.88% (prev 73.77%)
Tobins Q-Ratio = 2.30 (Enterprise Value 72.50b / Total Assets 31.50b)
Interest Expense / Debt = 0.83% (Interest Expense 247.0m / Debt 29.84b)
Taxrate = 1.42% (4.00m / 281.0m)
NOPAT = -2.94b (EBIT -2.98b * (1 - 1.42%)) [loss with tax shield]
Current Ratio = 0.26 (Total Current Assets 1.11b / Total Current Liabilities 4.30b)
Debt / Equity = -19.99 (negative equity) (Debt 29.84b / totalStockholderEquity, last quarter -1.49b)
Debt / EBITDA = -14.62 (negative EBITDA) (Net Debt 29.61b / EBITDA -2.03b)
Debt / FCF = 11.11 (Net Debt 29.61b / FCF TTM 2.67b)
Total Stockholder Equity = -1.07b (last 4 quarters mean from totalStockholderEquity)
RoA = -14.66% (Net Income -4.62b / Total Assets 31.50b)
RoE = 433.5% (negative equity) (Net Income TTM -4.62b / Total Stockholder Equity -1.07b)
RoCE = -13.31% (EBIT -2.98b / Capital Employed (Equity -1.07b + L.T.Debt 23.47b))
RoIC = -12.60% (negative operating profit) (NOPAT -2.94b / Invested Capital 23.33b)
WACC = 5.97% (E(42.89b)/V(72.73b) * Re(9.56%) + D(29.84b)/V(72.73b) * Rd(0.83%) * (1-Tc(0.01)))
Discount Rate = 9.56% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 0.35%
[DCF Debug] Terminal Value 74.15% ; FCFE base≈2.25b ; Y1≈2.42b ; Y5≈2.97b
Fair Price DCF = 91.56 (DCF Value 39.87b / Shares Outstanding 435.5m; 5y FCF grow 8.50% → 3.0% )
EPS Correlation: -39.61 | EPS CAGR: -13.38% | SUE: 0.03 | # QB: 0
Revenue Correlation: -74.05 | Revenue CAGR: -16.57% | SUE: 0.08 | # QB: 0
Additional Sources for CCI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle